Functional evaluation techniques in mitochondrial disorders

European Neurology

Volumn 39, Issue 2, 1998, Pages 65-71

  Argov, Zohar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Exercise; Lactate; Magnetic resonance spectroscopy; Mitochondrial encephalomyopathies; MRI; PET

Indexed keywords

BRAIN METABOLISM; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC PROCEDURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE TEST; FOLLOW UP; HUMAN; IMAGING; LACTATE BLOOD LEVEL; MUSCLE METABOLISM; OXIMETRY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EVALUATION STUDIES; EXERCISE TEST; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MITOCHONDRIAL ENCEPHALOMYOPATHIES; PHOSPHORUS; PROTONS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031892603     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007912     Document Type: Review

References (42)

1. Shoffner JM, Wallace DC: Oxidative phosphorylation diseases; in Scriver CR, Beaudet AL, Sly WS, Walle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw Hill, 1995, pp 1535-1609.
2. Karpati G, Arnold D, Matthews P, Carpenter S, Andermann F, Shoubridge E: Correlative multidisciplinary approach to the study of mitochondrial encephalomyopathies. Rev Neurol (Paris) 1991;147:455-461.
3. Walker UA, Collins S, Byrne E: Respiratory chain encephalomyopathies: A diagnostic classification. Eur Neurol 1996;36:260-267.
4. Peterson PL: The treatment of mitochondrial myopathies and encephalomyopathies. Biochem Biophys Acta 1995;1271:275-280.
5. Chi CS, Mak SC, Shian WJ, Chen CH: Oral glucose lactate stimulation test in mitochondrial diseases. Pediatr Neurol 1992;8:445-449.
6. Bresolin N, Doriguzzi C, Ponzetto C, Angelini C, Moroni I, Castelli E, Cossutta E, Binda A, Gallanti A, Gabellini S, Piccolo G, Martinuzzi A, Ciafaloni E, Arnaudo E, Liciardello I, Carenzi A, Scarlato G: Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 1990; 100:70-78.
7. Taivassalo T, Matthews PM, De Stefano N, Sripathi N, Genge A, Karpati G, Arnold DL: Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency. Neurology 1996;47:529-534.
8. Heiman-Patterson TD, Argov Z, Di Mauro S, Bonilla EB, Bank W, Tahmoush AJ: Biochemical and genetic studies in a family with mitochondrial myopathy. Muscle Nerve, in press.
9. Brooke MH, Carroll JE, Davis JE, Hagberg JM: The prolonged exercise test. Neurology 1979; 29:636-643.
10. Dengler R, Wohlfarth K, Zierz S, Jobges M, Schubert M: Muscle fatigue, lactate, and pyruvate in mitochondrial myopathy with progressive external ophthalmoplegia. Muscle Nerve 1996;19:45-462.
11. Nashef L, Lane RJM: Screening for mitochondrial cytopathies: The sub-anaerobic threshold exercise test (SATET). J Neurol Neurosurg Psychiatry 1989;52:1090-1094.
12. Haller RG, Lewis SF, Estabrook RW, DiMauro S, Servidei S, Foster DW: Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J Clin Invest 1989;84:155-161.
13. Elliot DL, Buist NR, Goldberg L, Kennawy N, Powel BR, Kuehl KS: Metabolic myopathies: Evaluation by graded exercise testing. Medicine 1989;68:163-172.
14. Siciliano G, Rossi B, Manca L, Angelini C, Tessa A, Vergani L, Martinuzzi A, Muratorio A: Residual muscle cytochrome c oxidase activity accounts for submaximal exercise lactate threshold in chronic progressive external ophthalmoplegia. Muscle Nerve 1996;19:342-349.
15. Taivassalo T, De Stephano N, Matthews PM, Argov Z, Genge A, Karpati G, Arnold DL: Aerobic training benefits patients with mitochondrial myopathies more than other chronic myopathies. Neurology 1997;48(suppl 3): A214.
16. Hooper RG, Thomas AR, Kearl RA: Mitochondrial enzyme deficiency causing exercise limitation in normal-appearing adult. Chest 1995;107:317-322.
17. Dandurand RJ, Matthews PM, Arnold DL, Eidelman DH: Mitochondrial disease. Pulmonary function, exercise performance and blood lactate levels. Chest 1995;108:182-189.
18. Argov Z, Bank WJ: Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Ann Neurol 1991;30:90-97.
19. Arnold DL, Taylor DJ, Radda GK: Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196.
20. Argov Z, Bank WJ, Maris J, Peterson P, Chance B: Bioenergetic heterogeneity of human mitochondrial myopathies: Phosphorus magnetic resonance spectroscopy study. Neurology 1987;37:257-262.
21. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL: In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 1991;41:114-120.
22. Kuhl CK, Layer G, Traber F, Zierz S, Block W, Reiser M: Mitochondrial encephalomyopathy: Correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology 1994;192: 223-230.
23. Taylor DJ, Kemp GJ, Radda GK: Bioenergetics of skeletal muscle in mitochondrial myopathy. J Neurol Sci 1994;127:198-206.
24. 31P-MRS study. NMR Biomed 1996;9:165-172.
25. Argov Z, De Stefano N, Taivassalo T, Chen J, Karpati G, Arnold DL: Abnormal oxidative metabolism in exercise intolerance of undetermined origin. Neuromuscul Disord 1997;7:99-104.
26. Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, Pierangeli G, Zaniol P, Lugaresi E: Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992;42:1209-1212.
27. Eleff SM, Barker PB, Blackband SJ, Chatham JC, Lutz NW, Johns DR, Bryan RN: Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol 1990;27:626-630.
28. Montagna P, Martinelli P, Cortelli P, Zaniol P, Lugaresi E, Barbiroli B: Brain 31P-magnetic resonance spectroscopy in mitochondrial cytopathies. Ann Neurol 1992;31:451-452.
29. Barbiroli B, Montagna P, Martinelli P, Lodi R, Iotti S, Cortelli P, Funicello R, Zaniol P: Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J Cereb Blood Flow Metab 1993;1:469-474.
30. Matthews PM, Berkovic SF, Shoubridge EA, Andermann F, Karpati G, Carpenter S, Arnold DL: In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial enecephalomyopathy (MERFF). Ann Neurol 1991;29:435-438.
31. Matthews PM, Andermann F, Silver K, Karpati G, Arnold DL: Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993; 43:2484-2490.
32. Cross JH, Gadian DG, Connelly A. Leonard JV: Proton magnetic resonance spectroscopy studies in lactic acidosis and mitochondrial disorders. J Inherit Metab Dis 1993;16:800-811.
33. Dubeau F, De Stefano N, Shoubridge EA, Zifkin BJ, Arnold DL: Investigation of a large kindred with the MELAS syndrome. Neurology 1997;48(suppl 3):A354.
34. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL: Short-term dichloroacetate (DCA) treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995;45:1193-1198.
35. 1H-MRS study. Neurology 1994;44: 557-559.
36. Frackowiak RS, Herold S, Petty RK, Morgan-Hughes JA: The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases. Brain 1988;111:1009-1024.
37. Berkovic SF, Carpenter S, Evans A, Karpati G, Shoubridge EA, Andermann F, Meyer E, Tyler JT, Diksic M, Arnold D, Wolfe LS, Anderrmann E, Hakim AM: Myoclonus epilepsy and ragged-red fibers (MERFF). Brain 1989;112: 1231-1260.
38. Shellock FG, Tyson LL, Fleckenstein JL: Diagnostic imaging of skeletal muscle exercise physiology and pathophysiology; in Fleckenstein JL, Crues JV, Reimers CD (eds): Muscle Imaging in Health and Disease. New York, Springer, 1996, pp 113-132.
39. Fleckenstein JL, Reimers CD, Haller RG: Inherited defects of muscle energy metabolism: Radiologic evaluation; in Fleckenstein JL, Crues JV, Reimers CD (eds): Muscle Imaging in Health and Disease. New York, Springer, 1996, pp 253-267.
40. 123I)-iodoamphetamine in two cases with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). Neuroradiology 1989; 31:358-361.
41. Chance B, Bank W: Genetic disease of mitochondrial function evaluated by NMR and NIR spectroscopy of skeletal tissue. Biochim Biophys Acta 1995;1271:7-14.
42. Bank W, Chance B: An oxidative defect in muscle metabolic myopathies: diagnosis by noninvasive tissue oxymetry. Ann Neurol 1994;36:830-837.